Jessica Nye, PhD

Researchers evaluated the effect of influenza vaccination on reducing antibiotic prescription outcomes for adults diagnosed with influenza-like illness.

Researchers evaluated whether finerenone treatment protects against pneumonia and COVID-19 in patients with chronic kidney disease and type 2 diabetes.

Adding tremelimumab and durvalumab to chemotherapy improves progression-free survival and overall survival in patients with metastatic non-small cell lung cancer, phase 3 data suggest.

Researchers evaluated outcomes among patients hospitalized with COVID-19 who received high- vs standard-dose dexamethasone.

Researchers sought to examine characteristics of and outcomes for patients with venothromboembolism and concomitant fibroids or gynecologic cancers.

Researchers established the therapeutic efficacy of topical blockade of substance P in managing patients with red eyes.

A study was conducted to determine 1-year outcomes following TAVR for patients receiving supplemental oxygen at home for treatment of COPD.

Researchers evaluated the efficacy of the SpikoGen® vaccine for protection against symptomatic COVID-19.

Researchers sought to determine if self-reported lung-related comorbidities was an indicator of poor outcomes on lung cancer screening.

First-line cemiplimab can improve long-term survival outcomes, compared with chemotherapy, in advanced non-small cell lung cancer.